// App-Quantinova.ai

TCT-47 : Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

Researchers

Presenter

  • Clemens von Birgelen

Principal Investigators

  • Kenneth Tandjung

  • Hanim Sen

  • Mounir Basalus

  • J Hans Louwerenburg

  • Martin Stoel

  • K Gert van Houwelingen

  • Gerard Linssen

  • Salah Said

  • Mark Nienhuis

  • Marije Lowik

Medical Centers

  • Streekziekenhuis Koningin Beatrix, Winterswijk, Netherlands

  • Thoraxcentrum Twente, Enschede, Netherlands

  • Research Methodology, Measurement and Data Analysis, University of Twente, Enschede, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved